Haemonetics is Celebrating 25 Years of Operations in Pittsburgh

News provided by

Oct 02, 2015, 07:00 ET

BRAINTREE, Mass., Oct. 2, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) THE Leader in Global Blood Management Solutions, will celebrate 25 years of manufacturing operations in the Pittsburgh community with employees and the local community.

WHAT: Haemonetics is holding a luncheon celebration of 25 years of operations in Pittsburgh for employees and local members of the community. Speakers will include: Thomas McCurdy, President Global Plasma and Brian Burns, Executive Vice President Global Quality Assurance & Regulatory Affairs. We will also feature a presentation from a patient of plasma therapy.

WHO: Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve patient care and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit the web site http://www.haemonetics.com

WHY: Since 1990, the Pittsburgh operations of Haemonetics has manufactured and distributed medical devices enabling over 150 million plasma collections and 3.5 million red blood cell collections! We want to thank the local Pittsburgh community for supporting our operations over the past 25 years with a talented work-force and committed community partners.

WHO SHOULD ATTEND: Local government officials, local media outlets, Haemonetics employees.

WHEN: October 9^th, 2015 from 11:00am – 2:00pm

WHERE: The Doubletree Hotel, 8402 University Blvd. Moon, PA 15108

MEDIA CONTACT: Laura Steele, 1-781-356-9747 [email protected]

EVENT CONTACT: Linda Bergman, 412-749-6277 [email protected]

SOURCE Haemonetics Corporation